46
Participants
Start Date
November 11, 2011
Primary Completion Date
October 30, 2014
Study Completion Date
March 1, 2018
Tacrolimus - Prograf® twice daily formulation
twice daily, dosage will be as determined by best treatment for each participant, duration of study period will be 4 months for each participant
Tacrolimus - Advagraf® once daily formulation
once daily, dosage will be as determined by best treatment for each participant, duration of study period will be 4 months for each participant
Solid Organ Transplant Clinic, Vancouver General Hospital, Vancouver
Simon Fraser University
OTHER
Astellas Pharma Canada, Inc.
INDUSTRY
University of British Columbia
OTHER